We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
Cap. Flow
-$375M
Cap. Flow %
-5.12%
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75

Top Buys

Rank Stock Value
1
ESE icon
ESCO Technologies
ESE
+$40.8M
2
HAE icon
Haemonetics
HAE
+$37.6M
3
ROG icon
Rogers Corp
ROG
+$26.2M
4
EVR icon
Evercore
EVR
+$25.5M
5
FARO
Faro Technologies
FARO
+$22M

Sector Composition

Rank Sector Weight
1 Industrials 25.72%
2 Technology 19.64%
3 Financials 14.17%
4 Consumer Discretionary 10.37%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNG icon
376
RingCentral
RNG
$4.66B
$5.09M 0.07%
24,000
CLDR
377
DELISTED
Cloudera, Inc.
CLDR
$5.06M 0.07%
642,600
+117,500
+22% +$1.15M
SCOR icon
378
Comscore
SCOR
$106M
$5.03M 0.07%
89,144
CHCT
379
Community Healthcare Trust
CHCT
$523M
$5.03M 0.07%
131,300
-33,500
-20% -$1.46M
MINI
380
DELISTED
Mobile Mini Inc
MINI
$5.02M 0.07%
191,532
SPCE icon
381
Virgin Galactic
SPCE
$328M
$4.98M 0.07%
16,848
-43,590
-72% -$16.6M
HUBG icon
382
HUB Group
HUBG
$2.85B
$4.96M 0.07%
218,226
+2,390
+1% +$60K
CENX icon
383
Century Aluminum
CENX
$4.43B
$4.91M 0.07%
1,356,554
+32,412
+2% +$181K
AVLR
384
DELISTED
Avalara, Inc.
AVLR
$4.87M 0.07%
65,300
+27,300
+72% +$2.23M
CAMP
385
DELISTED
CalAmp Corp.
CAMP
$4.87M 0.07%
47,051
+2,499
+6% +$489K
CHRS icon
386
Coherus Oncology
CHRS
$217M
$4.84M 0.07%
+298,512
New +$5.52M
AMWD
387
DELISTED
American Woodmark
AMWD
$4.83M 0.07%
105,989
+11,684
+12% +$1.08M
UFI icon
388
UNIFI
UFI
$119M
$4.81M 0.07%
416,141
+33,735
+9% +$692K
IRDM icon
389
Iridium Communications
IRDM
$5.02B
$4.77M 0.07%
213,530
-5,500
-3% -$142K
FAF icon
390
First American
FAF
$7.66B
$4.76M 0.06%
112,356
-3,900
-3% -$223K
BE icon
391
Bloom Energy
BE
$60.6B
$4.76M 0.06%
910,574
+122,500
+16% +$1.04M
VRAY
392
DELISTED
ViewRay, Inc.
VRAY
$4.73M 0.06%
1,892,173
+1,329,173
+236% +$3.76M
HCKT icon
393
Hackett Group
HCKT
$270M
$4.72M 0.06%
371,147
+58,181
+19% +$873K
GOOS
394
Canada Goose Holdings
GOOS
$872M
$4.7M 0.06%
236,379
+50,400
+27% +$1.41M
LUNA
395
DELISTED
Luna Innovations Incorporated
LUNA
$4.69M 0.06%
763,278
+463,478
+155% +$3.43M
CLGX
396
DELISTED
Corelogic, Inc.
CLGX
$4.67M 0.06%
152,900
-98,000
-39% -$4.34M
STRL icon
397
Sterling Infrastructure
STRL
$18.3B
$4.62M 0.06%
486,540
+2,366
+0.5% +$30.1K
DLB icon
398
Dolby
DLB
$5.51B
$4.59M 0.06%
84,640
-9,900
-10% -$649K
BLFS icon
399
BioLife Solutions
BLFS
$1.53B
$4.57M 0.06%
480,716
+260,000
+118% +$3.57M
FLXN
400
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4.54M 0.06%
576,494
+235,192
+69% +$3.54M

Similar funds

Royce & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.

  • Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
  • Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
  • Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
  • Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
  • Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
  • Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
  • Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.